期刊文献+

双歧三联活菌胶囊联合莫沙必利治疗功能性便秘的临床分析 被引量:14

原文传递
导出
摘要 目的探讨双歧三联活菌胶囊联合莫沙必利治疗功能性便秘的临床疗效及安全性。方法将200例功能性便秘的患者随机分为两组,治疗组100例给予双歧三联活菌胶囊420 mg,每日2次,餐后服用;同时应用莫沙必利5 mg,每日3次,餐前服用,共4~8周。对照组100例应用莫沙必利5 mg,每日3次,餐前服用,共4~8周。同时两组患者均给予调节饮食,改变生活方式,调整心理状态等治疗。结果治疗组临床显效率为80%,总有效率为96%;对照组临床显效率为61%,总有效率为75%,两组比较差异有统计学意义(P<0.05)。两组不良反应主要为腹痛、腹泻、头晕和转氨酶轻度升高,两组比较差异无统计学意义(P>0.05)。结论双歧三联活菌胶囊联合莫沙必利治疗功能性便秘安全有效。
作者 杨琦
出处 《临床医学》 CAS 2012年第9期59-60,共2页 Clinical Medicine
  • 相关文献

参考文献4

二级参考文献72

  • 1师延明,王美清,马永寿,郭金艳.微生态制剂预防新生儿抗生素相关性腹泻的Meta分析[J].中国微生态学杂志,2006,18(3):252-254. 被引量:33
  • 2WESTON S, HALBERT A, RICHMOND P, et al. Effects of probiotics on atopic dermatitis: a randomised controlled trial [J]. Arch Dis Child ,2005,90(9) :892-897.
  • 3BESSELINK M G,van SANTVOORT H C, BUSKENS E,et al. Boer-Probiotic prophylaxis in predicted severe acute pancreatitis: a randomised, double-blind, placebo-controlled trial [J]. Lancet, 2008, 371 (9613) :651-659.
  • 4Food and Agriculture Organization of the United Nations and World Health Organization (FAO-WHO) (2002). Guideline for the evaluation of probioties in food [P]. FAO of the United Nations and WHO working group report; Online:http://who. int/foodsafety/publications. fs-management/probioties/en/
  • 5SALMINEN S, ARVILOMMI H. Probiotic demonstrating efficacy in clinical setting [J]. Clin lnfrct Dis,2001,32 ( 6 ) : 1577 -1578.
  • 6LIVIN-LE MOAL V, SARRAZIN-DAVILA L E, SERVIN A L. An experimental study and a randomized, double-blind, placebo-controlled clinical trial to evaluate the antisecretory activity of Lactobacillus acidophilus strain LB against nonmtavirus diarrhea[J]. Pediatrics,2007, 120(4) :795-803.
  • 7DROUAULT-HOLOWACZ S, BIEUVELET S, BURCKEL A,et al. A double blind randomized controlled trial of a probiofic combination in 100 patients with irritable bowel syndrome[J]. Gastroenterol Clin Biol, 2008,32 (2) : 147-152.
  • 8GEIER M S, BUTLER R N, HOWARTH G S. Inflammatory bowel disease: current insights into pathogenesis and newtherapeutic options; probiotics, prebiotics and synbiotics [ J ]. Int J Food Microbiol,2007, 115(1):1-11.
  • 9IMASE K, TANAKA A,TOKUNAGA K, et al. Lactobacillus reuteri tablets suppress Helicobacter pylori infection-adouble-blind randomised placebo-controlled cross-over clinical study [J]. Kansenshogaku Zasshi ,2007,81 (4) : 387-393.
  • 10RAFTER J. Probiotics and colon cancer[J]. Best Pract Res Clin Gastroenterol, 2003,17 ( 5 ) : 849-859.

共引文献293

同被引文献103

引证文献14

二级引证文献100

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部